Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
EZZ Life Science Holdings Ltd. ( (AU:EZZ) ) has provided an update.
EZZ Life Science Holdings Limited has announced a fully franked interim dividend of $0.020 per share for the half year ending 31 December 2024. This decision reflects the company’s commitment to rewarding shareholders and may enhance investor confidence. The dividend will be paid on 17 June 2025, with the ex-dividend date set for 16 May 2025 and the record date on 19 May 2025.
More about EZZ Life Science Holdings Ltd.
EZZ Life Science Holdings Limited is a genomic life science company focused on enhancing quality of life and human health. The company invests in consumer health through e-commerce and distribution of high-quality products via omnichannel models across Australia, New Zealand, China, and globally. EZZ is also expanding into the United States, a key growth market.
YTD Price Performance: -54.23%
Average Trading Volume: 52,227
Technical Sentiment Signal: Buy
Current Market Cap: A$66.28M
For detailed information about EZZ stock, go to TipRanks’ Stock Analysis page.